The statistical analysis demonstrated that the positive expression rate of HER-2 was significantly up-regulated in breast cancer tissues compared with adjacent tissues (P<0.05) (Figure 1C), which indicated a higher level of HER-2 expression in breast cancer tissues. Here, ERBB2 is linked to breast carcinoma.